Comparison of mothers diet without cow protein and normal diet in the incidence of necrotizing enterocolitis in newborns with birth weight less than 1500 g
Phase 3
Recruiting
- Conditions
- necrotizing enterocolitis , diet without cow protein, newborns.necrotizing enterocolitis in newbornP77.1
- Registration Number
- IRCT20200415047086N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 104
Inclusion Criteria
Mothers consent to participate in the study
Mothers with newborns with birth weight less than 1500 g
Exclusion Criteria
No mothers consent to participate in the study
Non-cooperation of mothers during the study
The newborn has any disease during study
The mother has any disease during study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therate of incidence of necrotizing enterocolitis in newborns with birth weight less than 1500 g. Timepoint: Before the intervention and 15 days after the intervention. Method of measurement: Abdominal radiography using Bell division scale.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link cow protein avoidance in maternal diets to reduced necrotizing enterocolitis risk in VLBW infants?
How does cow protein-free maternal diet compare to standard enteral nutrition in preventing NEC in preterm neonates?
Are there specific biomarkers that identify VLBW infants most likely to benefit from maternal cow protein restriction?
What adverse gastrointestinal effects are associated with maternal cow protein elimination in VLBW infant care?
How do maternal dietary interventions without cow protein interact with probiotic therapies for NEC prevention in preterm neonates?